A detailed history of Wells Fargo & Company transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 35,296 shares of APLT stock, worth $271,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,296
Previous 435 8014.02%
Holding current value
$271,779
Previous $2,000 8100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.04 - $6.37 $140,838 - $222,064
34,861 Added 8014.02%
35,296 $164,000
Q1 2024

May 10, 2024

BUY
$2.25 - $7.4 $15 - $51
7 Added 1.64%
435 $2,000
Q4 2023

Feb 09, 2024

SELL
$1.84 - $3.35 $139 - $254
-76 Reduced 15.08%
428 $1,000
Q3 2023

Nov 13, 2023

BUY
$1.26 - $2.77 $204 - $448
162 Added 47.37%
504 $1,000
Q2 2023

Aug 15, 2023

BUY
$0.77 - $1.8 $53 - $124
69 Added 25.27%
342 $0
Q1 2023

May 12, 2023

BUY
$0.75 - $1.21 $3 - $6
5 Added 1.87%
273 $0
Q4 2022

Feb 13, 2023

BUY
$0.54 - $1.12 $3 - $7
7 Added 2.68%
268 $0
Q3 2022

Nov 14, 2022

BUY
$0.86 - $1.55 $122 - $220
142 Added 119.33%
261 $0
Q2 2022

Aug 12, 2022

SELL
$0.76 - $2.64 $1,022 - $3,553
-1,346 Reduced 91.88%
119 $0
Q1 2022

May 16, 2022

SELL
$1.48 - $6.22 $9,257 - $38,906
-6,255 Reduced 81.02%
1,465 $3,000
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $67,686 - $141,162
7,718 Added 385900.0%
7,720 $69,000
Q2 2021

Aug 16, 2021

SELL
$14.05 - $25.04 $33,846 - $60,321
-2,409 Reduced 99.92%
2 $0
Q1 2021

May 13, 2021

SELL
$16.57 - $28.65 $122,187 - $211,265
-7,374 Reduced 75.36%
2,411 $45,000
Q4 2020

Feb 09, 2021

BUY
$15.44 - $24.23 $5,203 - $8,165
337 Added 3.57%
9,785 $215,000
Q3 2020

Nov 05, 2020

SELL
$19.43 - $35.36 $48,302 - $87,904
-2,486 Reduced 20.83%
9,448 $196,000
Q2 2020

Aug 13, 2020

BUY
$29.41 - $51.23 $195,782 - $341,038
6,657 Added 126.15%
11,934 $432,000
Q1 2020

May 14, 2020

BUY
$19.54 - $55.47 $103,112 - $292,715
5,277 New
5,277 $172,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $370M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.